Yanping Hu

810 total citations
18 papers, 490 citations indexed

About

Yanping Hu is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Yanping Hu has authored 18 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Genetics. Recurrent topics in Yanping Hu's work include SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and CRISPR and Genetic Engineering (4 papers). Yanping Hu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers) and CRISPR and Genetic Engineering (4 papers). Yanping Hu collaborates with scholars based in China, United States and India. Yanping Hu's co-authors include William Siders, Johanne Kaplan, Jacqueline D. Shields, Bruce Roberts, Elizabeth Hutto, Wei Li, William Weber, Paula Boutin, Srinivas Shankara and Qi Zhou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Yanping Hu

17 papers receiving 478 citations

Peers

Yanping Hu
Sarah F. Brooks United States
Nobuhiko Imahashi Japan
R K Lee United States
Tetsuo Nagatani Japan
Hui-Chen Hsu Taiwan
Valérie Vilmont France
Е. В. Скоробогатова Russia
Bernard Frangoulis France
Gabriella Huerta United States
Sarah F. Brooks United States
Yanping Hu
Citations per year, relative to Yanping Hu Yanping Hu (= 1×) peers Sarah F. Brooks

Countries citing papers authored by Yanping Hu

Since Specialization
Citations

This map shows the geographic impact of Yanping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Hu more than expected).

Fields of papers citing papers by Yanping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Hu. The network helps show where Yanping Hu may publish in the future.

Co-authorship network of co-authors of Yanping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanping Hu. A scholar is included among the top collaborators of Yanping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanping Hu. Yanping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hu, Yanping, Jing Zou, Jason Yeung, et al.. (2025). Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3. mBio. 16(6). e0350324–e0350324. 2 indexed citations
2.
Sun, Long, Jing Zou, Yanping Hu, et al.. (2025). Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688. Proceedings of the National Academy of Sciences. 122(13). e2426922122–e2426922122. 1 indexed citations
3.
Grunst, Michael W., Zhuan Qin, Shilei Ding, et al.. (2024). Structure and inhibition of SARS-CoV-2 spike refolding in membranes. Science. 385(6710). 757–765. 20 indexed citations
4.
Zou, Jing, Chaitanya Kurhade, Yanping Hu, et al.. (2023). An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay. Viruses. 15(9). 1855–1855. 3 indexed citations
5.
Wang, Chenxin, Yangcan Chen, Na Tang, et al.. (2023). High-efficiency targeted transgene integration via primed micro-homologues. Cell Discovery. 9(1). 69–69. 8 indexed citations
6.
Wang, Xinge, Yangcan Chen, Siqi Wang, et al.. (2023). CDetection.v2: One-pot assay for the detection of SARS-CoV-2. Frontiers in Microbiology. 14. 1158163–1158163. 7 indexed citations
7.
Hu, Yanping, Jing Zou, Chaitanya Kurhade, et al.. (2023). Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1. Emerging Microbes & Infections. 12(2). 2271089–2271089. 29 indexed citations
8.
Chen, Yangcan, Yanping Hu, Xinge Wang, et al.. (2022). Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing. The Innovation. 3(4). 100264–100264. 36 indexed citations
9.
Li, Yuhuan, Guihai Feng, Min Dai, et al.. (2022). Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons. Advanced Science. 9(13). e2104682–e2104682. 12 indexed citations
10.
Hu, Yanping & Wei Li. (2022). Development and Application of CRISPR-Cas Based Tools. Frontiers in Cell and Developmental Biology. 10. 834646–834646. 14 indexed citations
11.
He, Zhengquan, Junjie Mao, Yanping Hu, et al.. (2019). Reprogramming of fibroblasts to uterine glandular epithelium by a chemical cocktail induction. Cell Discovery. 5(1). 2 indexed citations
12.
Hu, Yanping, Mohammed Salman Shazeeb, Carlos E. Pedraza, et al.. (2018). In Vivo Optical Imaging of Myelination Events in a Myelin Basic Protein Promoter-Driven Luciferase Transgenic Mouse Model. ASN NEURO. 10(1). 1663354609–1663354609. 7 indexed citations
13.
Hu, Yanping, Jacqueline D. Shields, Tri‐Hung Nguyen, et al.. (2011). Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leukemia & lymphoma. 53(1). 130–138. 24 indexed citations
14.
Siders, William, Jacqueline D. Shields, Yanping Hu, et al.. (2010). Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models. Leukemia & lymphoma. 51(7). 1293–1304. 61 indexed citations
15.
Hu, Yanping, Jacqueline D. Shields, Elizabeth Hutto, et al.. (2009). Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model. Immunology. 128(2). 260–270. 260 indexed citations
16.
Siders, William, et al.. (2009). Treatment with the CXCR4 Antagonist AMD3100 Enhances Antibody Mediated Killing in Disseminated Lymphoma Models.. Blood. 114(22). 2717–2717. 2 indexed citations
17.
Hu, Yanping, Jacqueline D. Shields, Lisa Woodworth, et al.. (2007). Alemtuzumab activity and CD52 expression in human CD52 transgenic mice. Cancer Research. 67. 4133–4133.
18.
Hu, Yanping, et al.. (1984). Spontaneous production of human gamma interferon in vitro by splenic lymphocytes of patients with idiopathic thrombocytopenic purpura.. PubMed. 56(2). 459–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah F. Brooks Breakdown of academic impact, for papers by Nobuhiko Imahashi Breakdown of academic impact, for papers by R K Lee Breakdown of academic impact, for papers by Tetsuo Nagatani Breakdown of academic impact, for papers by Hui-Chen Hsu Breakdown of academic impact, for papers by Valérie Vilmont Breakdown of academic impact, for papers by Е. В. Скоробогатова Breakdown of academic impact, for papers by Bernard Frangoulis Breakdown of academic impact, for papers by Gabriella Huerta
Rankless by CCL
2026